Tags : Advanced or Metastatic Cancers


Bristol-Myers (BMS) Collaborates with Vedanta Biosciences to Develop Combination Therapy

Shots: BMS to make equity investment in Vedanta and Vedanta will evaluate Opdivo + VE800, for advanced or metastatic cancers The focus of the collaboration is to develop combination therapy and to research aspect of microbes in advanced or metastatic cancers Opdivo (nivolumab) is a programmed death-1 (PD-1) immune checkpoint inhibitor, approved to treat multiple […]Read More